KEGG   DRUG: Elritercept
Entry
D12891                      Drug                                   
Name
Elritercept (USAN/INN)
Formula
C3380H5146N906O1052S40
Exact mass
76538.5857
Mol weight
76587.15
Sequence
GAILGRSETQ ECLFYNANWE LERTNQTGVE RCEGEKDKRL HCYATWRNIS GSIEIVKKGC
WLDDFNCYDR TDCVETEENP QVYFCCCEGN MCNEKFSYFP EMEVTQPTSG GGDKTHTCPP
CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK
TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV
YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS
KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPG
(Disulfide bridge: 12-42, 32-60, 67-86, 73-85, 87-92, 118-118', 121-121', 153-213, 259-317, 12'-42', 32'-60', 67'-86', 73'-85', 87'-92', 153'-213', 259'-317)
  Type
Peptide
Efficacy
Antineoplastic, Hematopoietic
Comment
Treatment of myelodysplastic syndromes and myelofibrosis
Target
ACVR2A [HSA:92] [KO:K04670]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04350  TGF-beta signaling pathway
hsa04550  Signaling pathways regulating pluripotency of stem cells
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor serine/threonine kinases (RSTK)
   TGFBR2 family
    ACVR2A
     D12891  Elritercept (USAN/INN)
Other DBs
CAS: 2727114-26-1
PubChem: 497621304
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system